CP and neurodegenerative disease: CP-mediated neuroinflammation has been suggested as a possible pathophysiological mechanism of AD and other neurodegenerative diseases (11, 12) and corroborated by reversal of AD-related cognitive decline and beta-amyloid deposition after introduction of CP targeted immune-suppression (38).